The estimated Net Worth of Andrew M. Oh is at least $415 dollars as of 15 May 2020. Andrew Oh owns over 5,000 units of Rubius Therapeutics Inc stock worth over $415 and over the last 6 years Andrew sold RUBY stock worth over $0.
Andrew has made over 1 trades of the Rubius Therapeutics Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Andrew exercised 5,000 units of RUBY stock worth $23,700 on 15 May 2020.
The largest trade Andrew's ever made was exercising 5,000 units of Rubius Therapeutics Inc stock on 15 May 2020 worth over $23,700. On average, Andrew trades about 833 units every 0 days since 2019. As of 15 May 2020 Andrew still owns at least 5,000 units of Rubius Therapeutics Inc stock.
You can see the complete history of Andrew Oh stock trades at the bottom of the page.
Andrew's mailing address filed with the SEC is C/O SYROS PHARMACEUTICALS, INC., 35 CAMBRIDGEPARK DRIVE, CAMBRIDGE, MA, 02140.
Over the last 6 years, insiders at Rubius Therapeutics Inc have traded over $2,165,279 worth of Rubius Therapeutics Inc stock and bought 305,000 units worth $6,624,680 . The most active insiders traders include Noubar Afeyan, Roger Pomerantz, and Robert Langer. On average, Rubius Therapeutics Inc executives and independent directors trade stock every 51 days with the average trade being worth of $2,709. The most recent stock trade was executed by Dannielle Appelhans on 24 February 2023, trading 10,385 units of RUBY stock currently worth $1,350.
developing a novel enucleated cell (ecell)(tm) therapy platform for unmet medical needs. founded by flagship venturelabs.
Rubius Therapeutics Inc executives and other stock owners filed with the SEC include: